Drug profile · INN
nintedanib
OFEV
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
nintedanib (OFEV) is an FDA-listed pharmaceutical active ingredient. Associated with Boehringer Ingelheim Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN nintedanib
Brand OFEV
Route ORAL
Formulation CAPSULE
ATC code L01EX09
Originator Boehringer Ingelheim Pty Ltd
Frequently asked questions
What is nintedanib?
nintedanib (OFEV) is an FDA-listed pharmaceutical active ingredient. Associated with Boehringer Ingelheim Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for nintedanib?
OFEV is a marketed brand name for nintedanib. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of nintedanib?
nintedanib has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.